Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est

Author: Benzinga Newsdesk | May 14, 2025 05:22pm
Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.

Posted In: BNGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist